Cargando…
Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria
Autores principales: | Ahmed, Nausheen, Li, Lucy, Rojas, Patricio, Covut, Fahrettin, Reese-Koc, Jane, Kolk, Merle, Malek, Ehsan, Metheny, Leland, O’Brien, Timothy, Caimi, Paolo, de Lima, Marcos, Cooper, Brenda W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189914/ https://www.ncbi.nlm.nih.gov/pubmed/33514923 http://dx.doi.org/10.1038/s41409-021-01223-y |
Ejemplares similares
-
Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens
por: Wang, Jiasheng, et al.
Publicado: (2023) -
Cord Blood Transplantation: Can We Make it Better?
por: Metheny, Leland, et al.
Publicado: (2013) -
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
por: Gonsalves, Wilson I., et al.
Publicado: (2018) -
Socioeconomic Factors and Survival of Multiple Myeloma Patients
por: Chamoun, Kamal, et al.
Publicado: (2021) -
Predicting Successful Phase Advancement and Regulatory Approval in
Multiple Myeloma From Phase I Overall Response Rates
por: Malek, Ehsan, et al.
Publicado: (2017)